Acadian Asset Management’s Tonix Pharmaceuticals TNXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-578
| Closed | -$39K | – | 2338 |
|
|
2024
Q2 | $39K | Buy |
578
+473
| +450% | +$31.9K | ﹤0.01% | 1626 |
|
|
2024
Q1 | $61K | Buy |
105
+76
| +262% | +$44.2K | ﹤0.01% | 1359 |
|
|
2023
Q4 | $37K | Buy |
29
+24
| +480% | +$30.6K | ﹤0.01% | 1497 |
|
|
2023
Q3 | $8K | Sell |
5
-16
| -76% | -$25.6K | ﹤0.01% | 1604 |
|
|
2023
Q2 | $108K | Buy |
21
+13
| +163% | +$66.9K | ﹤0.01% | 1393 |
|
|
2023
Q1 | $94K | Sell |
8
-37
| -82% | -$435K | ﹤0.01% | 1402 |
|
|
2022
Q4 | $349K | Buy |
+45
| New | +$349K | ﹤0.01% | 1137 |
|
|
2022
Q3 | – | Sell |
-23
| Closed | -$712K | – | 1850 |
|
|
2022
Q2 | $712K | Buy |
+23
| New | +$712K | ﹤0.01% | 890 |
|
|
2020
Q1 | – | Hold |
0
| – | -$46K | – | 1942 |
|
|
2019
Q4 | – | Hold |
0
| – | -$27K | – | 1614 |
|
|
2019
Q3 | – | Hold |
0
| – | -$89K | – | 1688 |
|
|
2019
Q2 | – | Hold |
0
| – | -$22K | – | 1386 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1809 |
|
|
2018
Q4 | – | Hold |
0
| – | -$4K | – | 1834 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 1629 |
|
|
2018
Q2 | – | Hold |
0
| – | -$53K | – | 1840 |
|
|
2018
Q1 | – | Hold |
0
| – | -$48K | – | 1345 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 1232 |
|